EP0455807A4 - Methods of coating viral antigens in the presence of nonionic detergents and acidic ph onto a solid phase - Google Patents

Methods of coating viral antigens in the presence of nonionic detergents and acidic ph onto a solid phase

Info

Publication number
EP0455807A4
EP0455807A4 EP19910902536 EP91902536A EP0455807A4 EP 0455807 A4 EP0455807 A4 EP 0455807A4 EP 19910902536 EP19910902536 EP 19910902536 EP 91902536 A EP91902536 A EP 91902536A EP 0455807 A4 EP0455807 A4 EP 0455807A4
Authority
EP
European Patent Office
Prior art keywords
solid phase
acidic
coating
viral antigens
onto
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910902536
Other versions
EP0455807A1 (en
Inventor
Bryan Francis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare Corp
Original Assignee
Baxter Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Diagnostics Inc filed Critical Baxter Diagnostics Inc
Publication of EP0455807A1 publication Critical patent/EP0455807A1/en
Publication of EP0455807A4 publication Critical patent/EP0455807A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses

Definitions

  • This invention relates to a process to coat viral antigens in the presence of nonionic detergent and acidic pH, onto a solid phase, to enhance the activity of bound viral antigens.
  • Antibodies are immobilized on solid phases, such as microtiter plates and latex beads, for use in research and diagnostic assays. Detection of monoclonal antibodies to membrane-associated proteins, however, presents a problem, since nonionic detergents used to
  • This invention relates to a method to increase the concentration of viral antigen on a solid phase by coating the solid phase with lu viral antigen in the presence of nonionic detergents, such as Triton X-l ⁇ U or NP4U, in acidic pH.
  • nonionic detergents such as Triton X-l ⁇ U or NP4U
  • Antigen was diluted into a coating buffer and added to lb particles.
  • the coating buffer was preferably comprised of 0.1 M acetate, pH b.O with 5* NP40, however, other nonionic detergents, such as Triton X-100, can be used. It was observed, however, that one nonionic detergent, Tween, did not result in a sufficiently high concentration of antigen to conduct an immunoassay.
  • 2U tion of detergent can range from .2% to 10 , with the optimum concentration from between about 1 and 10%. It was observed that pH can range from 4.U to 6.U, with the optimum pH at 5.0.
  • Buffer A was comprised of b 0.1 M acetate, at a pH 5.0.
  • Buffer B was comprised of 0.1 M acetate, 0.1 M NaCl, at a pH 5.0.
  • Buffer C was comprised of 0.1 M acetate, 0.1 M NaCl, 0.2% NP40, at a pH 5.0.
  • HIV negative serum was designated "617", positive was designated “618", and high positive serum was designated “R-J 1825”.
  • SDB sample dilution buffer
  • the dialyzed preparation was coated at 1/2 dilution with coating buffers A, B, and C on to 1 ml of 2.5% carboxylated paramagnetic particles (3.5 urn). Particles were incubated overnight at 2 Q 8 lb C. The particles were pelleted, the supernatent was discarded, and the particles were resuspended in 1% normal goat serum (NGS) in 0.1 M acetate, at a pH 5.0.
  • NGS normal goat serum
  • the coated particles were incubated for two hours at room temperature, then washed three times with 1 L isotonic buffered U saline (IBS).
  • IBS isotonic buffered U saline
  • the coating buffer "C” comprised of 0.1 M acetate, 0.1 M NAC1 , 30 and 0.2A NP40, and resulted in a greater concentration of viral antigens on the solid phase.
  • AIDS antigens coated in the presence of nonionic detergents and acidic pH resulted in viral coated particles witn enhanced activity over particles coated using other buffers.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

This invention relates to a process to enhance the activity of viral antigens that are bound to a solid phase. The viral antigens are coated to a solid phase in the presence of a nonionic detergeent, such as Triton X-100 or NP40, in a solution having an acidic pH.

Description

Methods of Coating Viral Antigens in the Presence of Nonionic Detergents and Acidic pH onto a Solid Phase
5 BACKGROUND OF THE INVENTION 1. Field of the Invention
This invention relates to a process to coat viral antigens in the presence of nonionic detergent and acidic pH, onto a solid phase, to enhance the activity of bound viral antigens.
1U 2. Description of the Prior Art
Antibodies are immobilized on solid phases, such as microtiter plates and latex beads, for use in research and diagnostic assays. Detection of monoclonal antibodies to membrane-associated proteins, however, presents a problem, since nonionic detergents used to
ID solubilize membrane antigens retard or prevent protein binding to latex microtiter wells. G. Urexler et al . , A Rapid and Simple Method for Efficient Coating of Microtiter Plates Using Low Amounts of Antigen in the Presence of Detergent, 95 J. Immuno. Metn. 117 (1986). Gardas et al., Coating of Proteins in the Presence of
2ϋ Detergents, 10b J. Immuno. Meth. 251 (1988). This problem nas been addressed in the past with a variety of solutions. One investigator suggested using glutoraldehyde to immobilize antigen in the presence of detergent. G. Evans, 73 J. Immuno. 427 (1984). Another investigator suggested the use of Bouin's fluid to increase the
2b binding of antigen -solubilize with a nonionic detergent. Notebooπ et al., 7b J. Immuno. Meth. 141 (1984). Still another investigator disclosed a process to increase the binding of antigen to a microtiter plate using beads to adsorb the residual nonionic detergent. See Drexler, supra. One author, however, suggested that iu proteins can oe effectively bound to latex surfaces provided that a detergent witn a hign critical micelle concentration (CMC), i.e. the concentration ot a detergent which allows the formation of micelles, is used. See Garαas, supra. This investigator tested the nonionic detergent, Triton X-100, among other detergents, at a concentration of .2 or .b% and a pH of 9.6. From this experiment, one skilled in the relevant art would conclude that this nonionic detergent, i.e. Triton X-100, inhibits binding at one of the lowest concentrations b and thus would appear to be a poor choice for use in an immunoassay.
SUMMARY OF THE INVENTION
This invention relates to a method to increase the concentration of viral antigen on a solid phase by coating the solid phase with lu viral antigen in the presence of nonionic detergents, such as Triton X-lύU or NP4U, in acidic pH.
DETAILED DESCRIPTION OF THE INVENTION
Antigen was diluted into a coating buffer and added to lb particles. The coating buffer was preferably comprised of 0.1 M acetate, pH b.O with 5* NP40, however, other nonionic detergents, such as Triton X-100, can be used. It was observed, however, that one nonionic detergent, Tween, did not result in a sufficiently high concentration of antigen to conduct an immunoassay. The concentra-
2U tion of detergent can range from .2% to 10 , with the optimum concentration from between about 1 and 10%. It was observed that pH can range from 4.U to 6.U, with the optimum pH at 5.0. Example 1 - Coating of HIV antigen onto magnetic microparticles using NP4D and acid pH.
2b 1 ml of 4 X 10**-* particles/ml of 3 - 4 micron carboxylated magnetic particles were pelleted and the supernatent was carefully removed and discarded. Tne particles were resuspended in 1 ml of 0.1 M acetate buffer, pH 5.0, containing b% NP40 and 250 ug/ml of HIV antigen. The particles were tumbled end over end at 5 - 6 rpm
3U overnignt at room temperature. The particles were pelleted and supernatent was discarded. The particles were resuspended in 1 ml oτ PBS, pelleted and tne supernatent was discarded. This was re- peated two times. The particles were resuspended in 1 ml of diluent (0.1M acetate, pH b.O, U.5M NAC1 , 1% NaN ) and stored at 2 - 8°. Example 2 - Comparison of coating conditions.
5 ml of solution containing HIV antigen, was dialyzed against three changes of four liters of 0.1 M acetate pH 5.0. Three different coating buffers were assessed: Buffer A was comprised of b 0.1 M acetate, at a pH 5.0. Buffer B was comprised of 0.1 M acetate, 0.1 M NaCl, at a pH 5.0. Buffer C was comprised of 0.1 M acetate, 0.1 M NaCl, 0.2% NP40, at a pH 5.0.
HIV negative serum was designated "617", positive was designated "618", and high positive serum was designated "R-J 1825". These 10 sera were diluted 1/100 in sample dilution buffer (SDB) (32% calf serum, 0.02M phosphate, pH 7.4, O.faM NAC1 , 1% NP40, and 0.1% NaN3).
The dialyzed preparation was coated at 1/2 dilution with coating buffers A, B, and C on to 1 ml of 2.5% carboxylated paramagnetic particles (3.5 urn). Particles were incubated overnight at 2 Q 8 lb C. The particles were pelleted, the supernatent was discarded, and the particles were resuspended in 1% normal goat serum (NGS) in 0.1 M acetate, at a pH 5.0.
The coated particles were incubated for two hours at room temperature, then washed three times with 1 L isotonic buffered U saline (IBS).
20ul of particles (1 X 107 parts/mL) were added to 50 ul of sample (1/lUO in SBD). This mixture was incubated for 30 minutes at 37°C. The solid phase was washed to remove unbound material. 50 ul of goat anti-human beta glactosidase labeled antibody was added to 5 the mixture. This mixture was then incubated for 15 minutes at 37°C. The mixture was washed to remove unbound antibody and 50 ul substrate (B-D-galactopyranoside) was added. The fluorescence was read at 2 and 14 minutes using a Pandex" FCA instrument. The results are reported below. D Tabl e 1
S D B 617 618 1825
10 Tabl e 2
S D B 617 618 1825
Buffer A 8 781.3 + 145.5 5449.7 (7.0) 19738 (25.3) Buffer B 7.5 970.7 +_ 130.6 5287.7 (5.4) 23484 (24.2) Buffer C 0 611.7 + 5y .5 5136.7 (8.4) 15434 (25.2) lb Cnannel Report : 400/450 Gai n Setti ng : 10 Read Time : 100 ms
Table 3
2U
25 Delta Read (Table 2 - Table 1)
Conclusions
The coating buffer "C" comprised of 0.1 M acetate, 0.1 M NAC1 , 30 and 0.2A NP40, and resulted in a greater concentration of viral antigens on the solid phase. AIDS antigens coated in the presence of nonionic detergents and acidic pH resulted in viral coated particles witn enhanced activity over particles coated using other buffers.

Claims

I Cl ai m:
1. An active solid phase coated with viral antigen made by the process comprising:
5 Coating a solid phase with viral antigen in an acidic suspension of a nonionic detergent, and a buffer.
2. The active solid phase of Claim 1 wherein the concentration of said detergent ranges from .2 to 10%.
3. The active solid phase of Claim 1 wherein said solid phase is a 10 paramagnetic microparticle.
4. The active solid phase of Claim 1 wherein said detergent is NP40 or Triton X-100. b. The active solid phase of Claim 1 wherein the pH of the suspension ranges from about 4.0 to 6.0. lb 6. Tne active solid phase of Claim 1 wherein the pH is about 5.0.
2U
b
3D
EP19910902536 1989-11-29 1990-11-28 Methods of coating viral antigens in the presence of nonionic detergents and acidic ph onto a solid phase Withdrawn EP0455807A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44363589A 1989-11-29 1989-11-29
US443635 2003-05-22

Publications (2)

Publication Number Publication Date
EP0455807A1 EP0455807A1 (en) 1991-11-13
EP0455807A4 true EP0455807A4 (en) 1992-07-08

Family

ID=23761588

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910902536 Withdrawn EP0455807A4 (en) 1989-11-29 1990-11-28 Methods of coating viral antigens in the presence of nonionic detergents and acidic ph onto a solid phase

Country Status (5)

Country Link
EP (1) EP0455807A4 (en)
JP (1) JPH04507003A (en)
AU (1) AU7160491A (en)
CA (1) CA2045682A1 (en)
WO (1) WO1991008311A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110596374A (en) * 2019-09-19 2019-12-20 潍坊市康华生物技术有限公司 Method for coupling magnetic particles and antigen

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0136798A2 (en) * 1983-08-25 1985-04-10 Biotech Research Laboratories Inc. Titre plate and assay kit for detection of antibodies in human serum and their production and use
EP0316495A1 (en) * 1987-11-19 1989-05-24 Iaf Biochem International Inc. Synthetic peptides useful for the detection of aids-related antibodies in human sera
EP0337785A1 (en) * 1988-04-14 1989-10-18 Johnson & Johnson Clinical Diagnostics, Inc. Diagnostic kit and method for rapid detection of antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870003A (en) * 1987-06-15 1989-09-26 Coulter Corporation Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0136798A2 (en) * 1983-08-25 1985-04-10 Biotech Research Laboratories Inc. Titre plate and assay kit for detection of antibodies in human serum and their production and use
EP0316495A1 (en) * 1987-11-19 1989-05-24 Iaf Biochem International Inc. Synthetic peptides useful for the detection of aids-related antibodies in human sera
EP0337785A1 (en) * 1988-04-14 1989-10-18 Johnson & Johnson Clinical Diagnostics, Inc. Diagnostic kit and method for rapid detection of antibodies

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BERGMEYER H.U. 'METHODS OF ENZYMATIC ANALYSIS, VOL. 10' 1986 , VCH , WEINHEIM,DE PAGES 469-483 " Human T-lymphotropic virus III / Lymphadenopathy-associated virus antibodies " V. Erfle et al. *
See also references of WO9108311A1 *

Also Published As

Publication number Publication date
EP0455807A1 (en) 1991-11-13
AU7160491A (en) 1991-06-26
WO1991008311A1 (en) 1991-06-13
CA2045682A1 (en) 1991-05-30
JPH04507003A (en) 1992-12-03

Similar Documents

Publication Publication Date Title
JPH02503950A (en) Simultaneous enzyme immunoassay for detecting human antigens and/or antibodies
CN108700584A (en) Labeled complex and preparation method thereof, kit, application and detecting system
US5141848A (en) Confirmatory immunoassay using microparticle separation
IE61407B1 (en) Enzyme immunoassay for detecting hiv antigens in hyman sera
JPH10197531A (en) Immunity dissociation to improve immunochemical measurement of inspection object substance
CA2097545C (en) Process for the immunochemical determination of an analyte
Granade et al. Rapid detection and differentiation of antibodies to HIV-1 and HIV-2 using multivalent antigens and magnetic immunochromatography testing
EP0455807A4 (en) Methods of coating viral antigens in the presence of nonionic detergents and acidic ph onto a solid phase
JPH05504400A (en) Antibody or antigen combination assays
EP0811165B1 (en) Detection of antibody production
CN112924666A (en) Solid support coating product, preparation method, application and product thereof
US5534414A (en) Process for preparing conjugates consisting of a specific binding partner and a carbohydrate-containing protein
JP2596959B2 (en) Ligand assays
JP2004301646A (en) Nonspecific reaction absorbent for immunity inspection
US20090317919A1 (en) Method for Assaying Antigens
CN108519481A (en) A method of improving core antibody magnetic microparticle chemiluminescence immune assay precision
JP3034104B2 (en) Washing solution containing metal ion complexing agent for solid-phase immunoassay and its use
NZ516587A (en) Assay
Menking et al. Antibodies in Air Assay: Application of ELISA to Aerosol Research.
Azze A new format ELISA for the detection of HBsAg
JP4359416B2 (en) Measuring method of substance immobilized on microparticle solid phase
CN115754266A (en) Sample diluent applied to indirect immunoassay
JPH11218534A (en) Nonspecific reaction absorbent and immunoassay using the absorbent
JPH05506722A (en) Modified vehicle proteins to improve enzyme-linked antibody immunosorbent assays
JP2021143946A (en) Suppression method of nonspecific reaction

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19910809

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE FR GB IT LI NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19920520

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE FR GB IT LI NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19920820